# Vir Biotechnology, Inc.: Form 8-K, filed Feb 23, 2026

- Company: [Vir Biotechnology, Inc.](/companies/vir.md) (CIK 1706431)
- Form: 8-K
- Filed: 2026-02-23
- Accepted by EDGAR: Feb 23, 2026, 17:16 ET
- Period: 2026-02-19
- Accession: 0001628280-26-010740
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1706431/000162828026010740/vir-20260219.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1706431/000162828026010740/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.02: Results of operations
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1706431/000162828026010740/vir-20260219.htm

Filed Feb 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-010740. Last ingested by Listed: Nov 2, 2026, 15:34 ET. No prices; not investment advice.